Log In
Print
BCIQ
Print
Print this Print this
 

Idalopirdine (Lu AE58054)

  Manage Alerts
Collapse Summary General Information
Company H. Lundbeck A/S
DescriptionSelective serotonin (5-HT6) receptor antagonist
Molecular Target Serotonin (5-HT6) receptor
Mechanism of ActionSerotonin (5-HT6) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner

Otsuka Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today